Modern approaches to the therapy of septic shock

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Bacteremia from gram-negative rods is a great cause of concern for hospital physicians today. Shock-complicating gram-negative sepsis has a mortality rate of 60% and above, despite early diagnosis and treatment. Intensive research efforts have shown new pathophysiological mechanisms and mediators involved in septic shock, with changes in recommented treatment protocols. In this report, the authors review the use of corticosteroids, fibronectin, naloxone hydrochloride, and immunotherapy, with emphasis on theoretical considerations and relevant clinical experience. Although these treatment methods may have been promising initially, data from large double-blind human trials are either lacking or unencouraging. While continued research and modern therapeutic approaches should improve future survival rates from septic shock, use of the therapies reviewed should be considered experimental at this time.

Original languageEnglish (US)
Pages (from-to)152-161
Number of pages10
JournalAmerican Journal of Emergency Medicine
Volume8
Issue number2
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Septic Shock
Therapeutic Human Experimentation
Convulsive Therapy
Clinical Protocols
Naloxone
Bacteremia
Fibronectins
Immunotherapy
Early Diagnosis
Shock
Sepsis
Adrenal Cortex Hormones
Survival Rate
Physicians
Mortality
Therapeutics
Research

Keywords

  • corticosteroids
  • endotoxin
  • fibronectin
  • immunotherapy
  • naloxone
  • Sepsis
  • septic shock
  • therapy

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Modern approaches to the therapy of septic shock. / Putterman, Chaim.

In: American Journal of Emergency Medicine, Vol. 8, No. 2, 1990, p. 152-161.

Research output: Contribution to journalArticle

@article{7749867ebfc94b439ffcccc3b154c8d9,
title = "Modern approaches to the therapy of septic shock",
abstract = "Bacteremia from gram-negative rods is a great cause of concern for hospital physicians today. Shock-complicating gram-negative sepsis has a mortality rate of 60{\%} and above, despite early diagnosis and treatment. Intensive research efforts have shown new pathophysiological mechanisms and mediators involved in septic shock, with changes in recommented treatment protocols. In this report, the authors review the use of corticosteroids, fibronectin, naloxone hydrochloride, and immunotherapy, with emphasis on theoretical considerations and relevant clinical experience. Although these treatment methods may have been promising initially, data from large double-blind human trials are either lacking or unencouraging. While continued research and modern therapeutic approaches should improve future survival rates from septic shock, use of the therapies reviewed should be considered experimental at this time.",
keywords = "corticosteroids, endotoxin, fibronectin, immunotherapy, naloxone, Sepsis, septic shock, therapy",
author = "Chaim Putterman",
year = "1990",
doi = "10.1016/0735-6757(90)90203-C",
language = "English (US)",
volume = "8",
pages = "152--161",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Modern approaches to the therapy of septic shock

AU - Putterman, Chaim

PY - 1990

Y1 - 1990

N2 - Bacteremia from gram-negative rods is a great cause of concern for hospital physicians today. Shock-complicating gram-negative sepsis has a mortality rate of 60% and above, despite early diagnosis and treatment. Intensive research efforts have shown new pathophysiological mechanisms and mediators involved in septic shock, with changes in recommented treatment protocols. In this report, the authors review the use of corticosteroids, fibronectin, naloxone hydrochloride, and immunotherapy, with emphasis on theoretical considerations and relevant clinical experience. Although these treatment methods may have been promising initially, data from large double-blind human trials are either lacking or unencouraging. While continued research and modern therapeutic approaches should improve future survival rates from septic shock, use of the therapies reviewed should be considered experimental at this time.

AB - Bacteremia from gram-negative rods is a great cause of concern for hospital physicians today. Shock-complicating gram-negative sepsis has a mortality rate of 60% and above, despite early diagnosis and treatment. Intensive research efforts have shown new pathophysiological mechanisms and mediators involved in septic shock, with changes in recommented treatment protocols. In this report, the authors review the use of corticosteroids, fibronectin, naloxone hydrochloride, and immunotherapy, with emphasis on theoretical considerations and relevant clinical experience. Although these treatment methods may have been promising initially, data from large double-blind human trials are either lacking or unencouraging. While continued research and modern therapeutic approaches should improve future survival rates from septic shock, use of the therapies reviewed should be considered experimental at this time.

KW - corticosteroids

KW - endotoxin

KW - fibronectin

KW - immunotherapy

KW - naloxone

KW - Sepsis

KW - septic shock

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=0025230376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025230376&partnerID=8YFLogxK

U2 - 10.1016/0735-6757(90)90203-C

DO - 10.1016/0735-6757(90)90203-C

M3 - Article

VL - 8

SP - 152

EP - 161

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 2

ER -